DNA methylation of <i>ARHGAP30</i> is negatively associated with <i>ARHGAP30</i> expression in lung adenocarcinoma, which reduces tumor immunity and is detrimental to patient survival

Sheng Hu; Wenxiong Zhang; Jiayue Ye; Yang Zhang; Deyuan Zhang; Jinhua Peng; Dongliang Yu; Jianjun Xu; Yiping Wei

doi:doi:10.18632/aging.203762

← Back

Research Paper Volume 13, Issue 24 pp 25799—25845

DNA methylation of ARHGAP30 is negatively associated with ARHGAP30 expression in lung adenocarcinoma, which reduces tumor immunity and is detrimental to patient survival

Figure 11. The correlation between the DNA methylation of ARHGAP30 and immune inhibitors. (A) Heat map of Spearman correlations between DNA methylation of ARHGAP30 and immune inhibitors across human cancers. (B1–B30) Scatter plots showing the negative correlation between DNA methylation of ARHGAP30 and immune inhibitors in the treatment of lung adenocarcinoma.